Elizabeth F.

Elizabeth F. has worked in various technology and leadership roles throughout their career. Elizabeth currently holds the position of Chief Information & Digital Officer at Numotion since 2020. In addition, they serve as a Director on the Board of Directors at NeoGenomics Laboratories starting in 2023.

Prior to these roles, Elizabeth was Vice President of Global Business Technology at Allergan (acquired by Abbvie) from 2019 to 2020. Elizabeth also served as the Head of Commercial & Digital Technology at Regeneron Pharmaceuticals, Inc. from 2016 to 2019.

Before their time at Regeneron, Elizabeth was Vice President of Global Commercial Technology at Baxter International Inc., specifically at Baxalta (BioScience spinoff of Baxter), from 2013 to 2016.

Overall, Elizabeth F. has a strong background in technology leadership, with experience in the pharmaceutical, medical, and biotech industries.

Elizabeth F. holds a Master of Business Administration (MBA) degree in Marketing from Benedictine University. Elizabeth also completed an Executive Education program in Chief Information Security Officer from the Heinz College of Information Systems and Public Policy at Carnegie Mellon University. Additionally, Elizabeth F. has a Bachelor of Science degree in Public Relations and Political Science from Illinois State University. Elizabeth also studied Information Systems at DePaul University.